Target
Mu-type opioid receptor
Ligand
BDBM179908
Substrate
n/a
Meas. Tech.
Opioid Receptor Binding Assay
Ki
1.30±0.4 nM
Citation
 Blumberg, LCDeaver, DREyerman, DJWynn, TA Methods for treating depressive symptoms US Patent  US11534436 Publication Date 12/27/2022 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM179908
Synonyms:
US10736890, Compound TABLE B.1 | US10752592, Compound nalbuphine | US11534436, Compound nalbuphine | US9133125, Table D, nalbuphine
Type:
Small organic molecule
Emp. Form.:
C21H27NO4
Mol. Mass.:
357.4434
SMILES:
O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 |r|
Structure:
Search PDB for entries with ligand similarity: